Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 15, 2004Science

Gene Therapy Insertional Mutagenesis Insights

View Full Paper
Ask AI
Bookmark
Share

Authors

UDUtpal P. DavéIndiana University HealthNJNancy A. JenkinsAgency for Science, Technology and Research
Neal G. Copeland
Neal G. CopelandThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Davé et al. (2004) studied this question.

synapsesocial.com/papers/6a6fa4ff660549caf2c42ebbhttps://doi.org/10.1126/science.1091667
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy2002 · 1,056 citations
  2. 2Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease2000 · 2,645 citations
  3. 3A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency2003 · 1,872 citations
  4. 4The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.1991 · 374 citations
  5. 5<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X12003 · 3,568 citations